ポイントオブケア（POC）分子診断ソリューションは、患者が最初に訪れたときに、迅速な診断技術と治療法の決定を組み合わせることで、標準的な治療の向上をもたらします。PoCの分子診断製品には、キット＆アッセイ、分析装置、ソフトウェア＆サービスがあり、呼吸器系疾患、感染症、血液学など様々な用途に幅広く使用されています。インドおよびその周辺国のPoC分子診断市場は、2021年から2026年までの予測期間中、16.34%のCAGRで成長すると予測されています。感染症の流行に対する関心の高まりや、これらの国の政府が医療インフラの整備に力を入れていることなどの要因が、市場の成長を後押しすると予想されます。さらに、これらの国では医療費が増加していることも、市場の成長を後押しすると予想されます。また、これらの国では、人口の増加や感染症の増加を理由に、市場の成長が見込まれています。インドとその周辺国のPoC分子診断市場は、2019年の約17億USドルの売上から、2026年末には約64億USドルに達すると予想されています。
市場は様々なセグメントに分かれており、エンドユーザー別、製品タイプ別、技術タイプ別、アプリケーション別、国別などに分類されています。技術タイプに基づいて、市場はPCR、DNAマイクロアレイ、等温増幅、遺伝子配列、ハイブリダイゼーション、その他に分類されますが、そのうちクリニックのエンドユーザーセグメントのPCRが最大の市場シェアを持ち、2021年末までに約5億8,000万USドルの収益を上げると予想されています。
国別では、インド、バングラデシュ、パキスタン、スリランカ、ネパール、モルディブに分けられますが、そのうちインドの市場が予測期間中最大のシェアを占めると予想されます。さらに、同国の市場は、経済成長と政府による医療費の増加を背景に、2026年末までに約53億USドルの収益を上げると予測されています。さらに、この国の市場は、予測期間中に17%という最も高いCAGRで成長すると予想されています。
目次
India and Neighboring Countries PoC Molecular Diagnostics Market TOC
1. Introduction
1.1. Market Definition
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Research Objective
2.2. Secondary Research
2.3. Primary Research
2.4. Market Size Estimation
3. Executive Summary - India and Neighboring Countries PoC Molecular Diagnostic Market
4. Analysis of Market Dynamics
4.1. Drivers
4.2. Restraints/Challenges
4.3. Trends
4.4. Opportunities
5. Risk Analysis
6. Impact of COVID-19 on PoC Molecular Diagnostic Market
7. End-User Usability Analysis
8. Average Pricing Analysis
9. India and Neighboring Countries PoC Molecular Diagnostic Market Outlook
9.1. Market Size and forecast, 2019-2026F
9.1.1. By Value (USD Million)
9.2. PoC Molecular Diagnostic Market Segmentation, 2019-2026F
9.2.1. By End-User
9.2.1.1. Hospitals, 2019-2026F (USD Million)
9.2.1.2. Clinics, 2019-2026F (USD Million)
9.2.1.3. Diagnostic Labs, 2019-2026F (USD Million)
9.2.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
9.2.1.5. Others, 2019-2026F (USD Million)
9.2.2. By Product
9.2.2.1. Kits & Assays, 2019-2026F (USD Million)
9.2.2.2. Analyzers, 2019-2026F (USD Million)
9.2.2.3. Software & Services, 2019-2026F (USD Million)
9.2.3. By Technology Type
9.2.3.1. PCR, 2019-2026F (USD Million)
9.2.3.2. DNA Microarray, 2019-2026F (USD Million)
9.2.3.3. Isothermal Amplification, 2019-2026F (USD Million)
9.2.3.4. Genetic Sequencing, 2019-2026F (USD Million)
9.2.3.5. Hybridization, 2019-2026F (USD Million)
9.2.3.6. Other, 2019-2026F (USD Million)
9.2.4. By Application
9.2.4.1. Respiratory Disease, 2019-2026F (USD Million)
9.2.4.2. Infectious Disease, 2019-2026F (USD Million)
9.2.4.3. Oncology, 2019-2026F (USD Million)
9.2.4.4. STDs, 2019-2026F (USD Million)
9.2.4.5. Prenatal Testing, 2019-2026F (USD Million)
9.2.4.6. Hematology, 2019-2026F (USD Million)
9.2.4.7. Hepatitis, 2019-2026F (USD Million)
9.2.4.8. Others, 2019-2026F (USD Million)
9.2.5. By Country
9.2.5.1. India, 2019-2026F (USD Million)
9.2.5.2. Bangladesh, 2019-2026F (USD Million)
9.2.5.3. Sri Lanka, 2019-2026F (USD Million)
9.2.5.4. Nepal, 2019-2026F (USD Million)
9.2.5.5. Pakistan, 2019-2026F (USD Million)
9.2.5.6. Maldives, 2019-2026F (USD Million)
10. India PoC Molecular Diagnostic Market
10.1. Market Overview
10.2. Market Size, 2019-2026F (USD Million)
10.3. Market Segmentation
10.3.1. By End-User
10.3.1.1. Hospitals, 2019-2026F (USD Million)
10.3.1.2. Clinics, 2019-2026F (USD Million)
10.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
10.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
10.3.1.5. Others, 2019-2026F (USD Million)
10.3.2. By Product
10.3.2.1. Kits & Assays, 2019-2026F (USD Million)
10.3.2.2. Analyzers, 2019-2026F (USD Million)
10.3.2.3. Software & Services, 2019-2026F (USD Million)
10.3.3. By Technology
10.3.3.1. PCR, 2019-2026F (USD Million)
10.3.3.2. DNA Microarray, 2019-2026F (USD Million)
10.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
10.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
10.3.3.5. Hybridization, 2019-2026F (USD Million)
10.3.3.6. Other, 2019-2026F (USD Million)
10.3.4. By Application
10.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
10.3.4.2. Infectious Disease, 2019-2026F (USD Million)
10.3.4.3. Oncology, 2019-2026F (USD Million)
10.3.4.4. STDs, 2019-2026F (USD Million)
10.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
10.3.4.6. Hematology, 2019-2026F (USD Million)
10.3.4.7. Hepatitis, 2019-2026F (USD Million)
10.3.4.8. Others, 2019-2026F (USD Million)
10.3.4.9. Software & Services, 2019-2026F (USD Million)
11. Bangladesh PoC Molecular Diagnostic Market
11.1. Market Overview
11.2. Market Size, 2019-2026F (USD Million)
11.3. Market Segmentation
11.3.1. By End-User
11.3.1.1. Hospitals, 2019-2026F (USD Million)
11.3.1.2. Clinics, 2019-2026F (USD Million)
11.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
11.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
11.3.1.5. Others, 2019-2026F (USD Million)
11.3.2. By Product
11.3.2.1. Kits & Assays, 2019-2026F (USD Million)
11.3.2.2. Analyzers, 2019-2026F (USD Million)
11.3.2.3. Software & Services, 2019-2026F (USD Million)
11.3.3. By Technology
11.3.3.1. PCR, 2019-2026F (USD Million)
11.3.3.2. DNA Microarray, 2019-2026F (USD Million)
11.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
11.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
11.3.3.5. Hybridization, 2019-2026F (USD Million)
11.3.3.6. Other, 2019-2026F (USD Million)
11.3.4. By Application
11.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
11.3.4.2. Infectious Disease, 2019-2026F (USD Million)
11.3.4.3. Oncology, 2019-2026F (USD Million)
11.3.4.4. STDs, 2019-2026F (USD Million)
11.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
11.3.4.6. Hematology, 2019-2026F (USD Million)
11.3.4.7. Hepatitis, 2019-2026F (USD Million)
11.3.4.8. Others, 2019-2026F (USD Million)
11.3.4.9. Software & Services, 2019-2026F (USD Million)
12. Sri Lanka PoC Molecular Diagnostic Market
12.1. Market Overview
12.2. Market Size, 2019-2026F (USD Million)
12.3. Market Segmentation
12.3.1. By End-User
12.3.1.1. Hospitals, 2019-2026F (USD Million)
12.3.1.2. Clinics, 2019-2026F (USD Million)
12.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
12.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
12.3.1.5. Others, 2019-2026F (USD Million)
12.3.2. By Product
12.3.2.1. Kits & Assays, 2019-2026F (USD Million)
12.3.2.2. Analyzers, 2019-2026F (USD Million)
12.3.2.3. Software & Services, 2019-2026F (USD Million)
12.3.3. By Technology
12.3.3.1. PCR, 2019-2026F (USD Million)
12.3.3.2. DNA Microarray, 2019-2026F (USD Million)
12.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
12.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
12.3.3.5. Hybridization, 2019-2026F (USD Million)
12.3.3.6. Other, 2019-2026F (USD Million)
12.3.4. By Application
12.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
12.3.4.2. Infectious Disease, 2019-2026F (USD Million)
12.3.4.3. Oncology, 2019-2026F (USD Million)
12.3.4.4. STDs, 2019-2026F (USD Million)
12.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
12.3.4.6. Hematology, 2019-2026F (USD Million)
12.3.4.7. Hepatitis, 2019-2026F (USD Million)
12.3.4.8. Others, 2019-2026F (USD Million)
12.3.4.9. Software & Services, 2019-2026F (USD Million)
13. Nepal PoC Molecular Diagnostic Market
13.1. Market Overview
13.2. Market Size, 2019-2026F (USD Million)
13.3. Market Segmentation
13.3.1. By End-User
13.3.1.1. Hospitals, 2019-2026F (USD Million)
13.3.1.2. Clinics, 2019-2026F (USD Million)
13.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
13.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
13.3.1.5. Others, 2019-2026F (USD Million)
13.3.2. By Product
13.3.2.1. Kits & Assays, 2019-2026F (USD Million)
13.3.2.2. Analyzers, 2019-2026F (USD Million)
13.3.2.3. Software & Services, 2019-2026F (USD Million)
13.3.3. By Technology
13.3.3.1. PCR, 2019-2026F (USD Million)
13.3.3.2. DNA Microarray, 2019-2026F (USD Million)
13.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
13.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
13.3.3.5. Hybridization, 2019-2026F (USD Million)
13.3.3.6. Other, 2019-2026F (USD Million)
13.3.4. By Application
13.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
13.3.4.2. Infectious Disease, 2019-2026F (USD Million)
13.3.4.3. Oncology, 2019-2026F (USD Million)
13.3.4.4. STDs, 2019-2026F (USD Million)
13.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
13.3.4.6. Hematology, 2019-2026F (USD Million)
13.3.4.7. Hepatitis, 2019-2026F (USD Million)
13.3.4.8. Others, 2019-2026F (USD Million)
13.3.4.9. Software & Services, 2019-2026F (USD Million)
14. Pakistan PoC Molecular Diagnostic Market
14.1. Market Overview
14.2. Market Size, 2019-2026F (USD Million)
14.3. Market Segmentation
14.3.1. By End-User
14.3.1.1. Hospitals, 2019-2026F (USD Million)
14.3.1.2. Clinics, 2019-2026F (USD Million)
14.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
14.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
14.3.1.5. Others, 2019-2026F (USD Million)
14.3.2. By Product
14.3.2.1. Kits & Assays, 2019-2026F (USD Million)
14.3.2.2. Analyzers, 2019-2026F (USD Million)
14.3.2.3. Software & Services, 2019-2026F (USD Million)
14.3.3. By Technology
14.3.3.1. PCR, 2019-2026F (USD Million)
14.3.3.2. DNA Microarray, 2019-2026F (USD Million)
14.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
14.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
14.3.3.5. Hybridization, 2019-2026F (USD Million)
14.3.3.6. Other, 2019-2026F (USD Million)
14.3.4. By Application
14.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
14.3.4.2. Infectious Disease, 2019-2026F (USD Million)
14.3.4.3. Oncology, 2019-2026F (USD Million)
14.3.4.4. STDs, 2019-2026F (USD Million)
14.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
14.3.4.6. Hematology, 2019-2026F (USD Million)
14.3.4.7. Hepatitis, 2019-2026F (USD Million)
14.3.4.8. Others, 2019-2026F (USD Million)
14.3.4.9. Software & Services, 2019-2026F (USD Million)
15. Maldives PoC Molecular Diagnostic Market
15.1. Market Overview
15.2. Market Size, 2019-2026F (USD Million)
15.3. Market Segmentation
15.3.1. By End-User
15.3.1.1. Hospitals, 2019-2026F (USD Million)
15.3.1.2. Clinics, 2019-2026F (USD Million)
15.3.1.3. Diagnostic Labs, 2019-2026F (USD Million)
15.3.1.4. Research & Academic Institutes, 2019-2026F (USD Million)
15.3.1.5. Others, 2019-2026F (USD Million)
15.3.2. By Product
15.3.2.1. Kits & Assays, 2019-2026F (USD Million)
15.3.2.2. Analyzers, 2019-2026F (USD Million)
15.3.2.3. Software & Services, 2019-2026F (USD Million)
15.3.3. By Technology
15.3.3.1. PCR, 2019-2026F (USD Million)
15.3.3.2. DNA Microarray, 2019-2026F (USD Million)
15.3.3.3. Isothermal Amplification, 2019-2026F (USD Million)
15.3.3.4. Genetic Sequencing, 2019-2026F (USD Million)
15.3.3.5. Hybridization, 2019-2026F (USD Million)
15.3.3.6. Other, 2019-2026F (USD Million)
15.3.4. By Application
15.3.4.1. Respiratory Disease, 2019-2026F (USD Million)
15.3.4.2. Infectious Disease, 2019-2026F (USD Million)
15.3.4.3. Oncology, 2019-2026F (USD Million)
15.3.4.4. STDs, 2019-2026F (USD Million)
15.3.4.5. Prenatal Testing, 2019-2026F (USD Million)
15.3.4.6. Hematology, 2019-2026F (USD Million)
15.3.4.7. Hepatitis, 2019-2026F (USD Million)
15.3.4.8. Others, 2019-2026F (USD Million)
15.3.4.9. Software & Services, 2019-2026F (USD Million)
16. Competitive Landscape
16.1. F. Hoffmann-La Roche Ltd
16.2. Bio-Rad Laboratories, Inc.
16.3. Molbio Diagnostics Pvt. Ltd.
16.4. bioMerieux SA
16.5. Becton, Dickinson and Company
16.6. QuantMDx Group Limited
16.7. Beckman Coulter, Inc.
16.8. Abbott
16.9. MedGenome
16.10. Chembio Diagnostics, Inc.
16.11. Sysmex Europe GmbH
16.12. Cepheid
